Astim Allerji Immunoloji最新文献_第7页

Is There An Effect of Inhaled Steroid Treatment on Heart Rate? 吸入类固醇治疗对心率有影响吗?

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.414

M. Y. Özkars, M. Argun

引用次数: 1

A Rare Case of Multiple Severe Anaphylaxis Caused by Thyme, Black Pepper, Wasp and Honey 百里香、黑胡椒、黄蜂和蜂蜜引起多发性严重过敏的罕见病例

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.448

M. Türk, I. Yilmaz

引用次数: 0

Comparison of Cross Reactions Between Cow’s Milk and Other Mammals’ Milk Using Skin Prick Test and Atopy Patch Test in Children with Atopic Dermatitis and Cow’s Milk Allergy 特应性皮炎和牛奶过敏儿童皮肤刺破试验和过敏性斑贴试验比较牛奶和其他母乳的交叉反应

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.441

Özlem Sancaklı, A. Yenigün, T. Tuncel

{"title":"Comparison of Cross Reactions Between Cow’s Milk and Other Mammals’ Milk Using Skin Prick Test and Atopy Patch Test in Children with Atopic Dermatitis and Cow’s Milk Allergy","authors":"Özlem Sancaklı, A. Yenigün, T. Tuncel","doi":"10.21911/AAI.441","DOIUrl":"https://doi.org/10.21911/AAI.441","url":null,"abstract":"Objective: The use of other mammals’ milk as an alternative treatment of cow’s milk allergy is controversial due to their similar protein structures. In the present study, we aimed to investigate cross reactions with sheep’s, goat, and camel’s milks using skin prick test and atopy patch test in children with cow’s milk allergy. Materials and Methods: Our study group was composed of patients with atopic dermatitis who were diagnosed with cow’s milk allergy in our former study where we investigated the sensitivity of different diagnostic tests commonly used to determine cow’s milk allergy. In all patients, cow’s milk, sheep’s milk, goat’s milk and camel’s milk were used for skin prick test and atopy patch test. The study data were analyzed with SPSS 20.0 for Windows. Results: Among the patients with cow’s milk allergy, 15 (63%) had early-onset and 9 (37%) late-onset reactions with provocation tests. Seven (70%) of 10 children who were found skin prick test positive with cow’s milk were shown to have a cross reaction against goat’s and sheep’s milk with skin prick test; 8 (88.8%) of 9 children who were found to be atopy patch test positive with cow’s milk had a cross reaction against goat’s milk, and 7 (66.6%) against sheep’s milk. No patient with cow’s milk allergy had a cross reaction with camel’s milk with either skin prick test or atopy patch test. Conclusion: Our study demonstrated that a cross reaction occurs at a quite high rate between cow’s milk, sheep’s milk and goat’s milk as revealed by both skin prick testing and atopy patch test, whereas there was no demonstrable cross reaction between cow’s milk and camel’s milk by either method.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2019-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41628716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Allergic Bronchopulmonary Aspergillosis: A Clinical Evaluation of 15 Patients and Successful Omalizumab Treatment of Five Patients 过敏性支气管肺曲霉病:15例临床评价及5例奥玛单抗治疗成功

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.476

D. Ünal

{"title":"Allergic Bronchopulmonary Aspergillosis: A Clinical Evaluation of 15 Patients and Successful Omalizumab Treatment of Five Patients","authors":"D. Ünal","doi":"10.21911/AAI.476","DOIUrl":"https://doi.org/10.21911/AAI.476","url":null,"abstract":"Objective: Allergic bronchopulmonary aspergillosis (ABPA) is an immunological lung disease caused by hypersensitivity reactions to Aspergillus antigen. Studies on the efficacy of omalizumab treatment in patients diagnosed with ABPA are limited to case reports and small series. Our aim was to evaluate the effectiveness of omalizumab treatment in ABPA in addition to clinical, radiological and serological characteristics these patients. Materials and Methods: This study is a prospective observational one. It included clinical review of 15 patients diagnosed with ABPA and the successful omalizumab treatment of 5 of these patients. Patients receiving omalizumab therapy were assessed at baseline, after 1 year and 3 years of starting treatment. Results: 15 patients (9 males, 6 females, mean age: 48.26 ± 9.92 years) diagnosed as ABPA were enrolled. One patient had received antituberculosis medications prior to diagnosis. The mean serum total IgE level was 1665 ± 909 IU/mL. The most common finding in thorax high-resolution computed tomography was central bronchiectasis. Omalizumab treatment was started in five patients with asthma and ABPA who have failed to respond to Global Initiative for Asthma step 4 treatment. Conclusion: ABPA should be considered in patients with uncontrolled or severe asthma, despite appropriate asthmatic treatment. Recognizing ABPA is important, because early diagnosis can delay the development or prevent the bronchiectasis that causes fibrotic lung disease. Omalizumab is an effective therapy option in patients with asthma and ABPA who fail to respond to Global Initiative for Asthma step 4 treatment.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2019-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47209292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

The Effect of Allergen Immunotherapy on Serum Periostin Levels in Children with Allergic Rhinitis 过敏原免疫治疗对变应性鼻炎患儿血清骨膜蛋白水平的影响

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.435

Hulya Ucaryilmaz, Ayça Emsen, Ahmet Hakan Dikener, Neriman Akdam, A. Unlu, H. Artaç

{"title":"The Effect of Allergen Immunotherapy on Serum Periostin Levels in Children with Allergic Rhinitis","authors":"Hulya Ucaryilmaz, Ayça Emsen, Ahmet Hakan Dikener, Neriman Akdam, A. Unlu, H. Artaç","doi":"10.21911/AAI.435","DOIUrl":"https://doi.org/10.21911/AAI.435","url":null,"abstract":"Objective: Periostin, an extracellular matrix protein, is related to the eosinophilic airway inflammation. There is no specific marker in allergen immunotherapy to evaluate clinical response. We aimed to investigate the serum periostin levels in the children who receive allergen immunotherapy. Materials and Methods: Sixteen patients between 8-18 years (12.7±2.8 years) with allergic rhinitis and/or asthma due to grass pollen hypersensitivity and 30 healthy subjects (11.7±2.6 years) were included. Demographic data, eosinophil counts, skin prick tests and the specific IgE levels of the patients are recorded. Symptom scores, visual analog scales, medication scores were determined and the serum periostin levels were measured in the beginning, 4th and 12th months of the allergen immunotherapy. Results: The symptom scores for rhinitis in the 4th month showed significant improvements in all of the patients (p<0.05). Nine patients with allergic rhinitis accompanied by asthma, showed significant improvements in 12th month symptom score for asthma (p=0.018). A significant correlation was detected between the initial serum periostin levels and the symptom scores for the eye (r=0.668, p=0.005). No significant difference was found in serum periostin levels between the patient and the control groups. There were no significant differences in serum periostin levels in 4th and 12th months compared to the ones in the beginning. Conclusion: In this study, there were no significant differences in serum periostin levels of children during the allergen immunotherapy. The association of serum periostin levels with symptom scores for the eye needs to be confirmed in more children with allergic rhinoconjunctivitis.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2019-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46017004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Primary Immunodeficiencies Associated with Atopic Dermatitis 原发性免疫缺陷与特应性皮炎

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.423

S. Esenboğa, B. Sekerel, I. Tezcan

引用次数: 0

Clinical Features of Patients with Chronic Urticaria and the Results of the Skin Prick Tests 慢性荨麻疹患者的临床特点及皮肤点刺试验结果

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-08-08 DOI: 10.21911/AAI.437

F. Bilgir, R. Özdemir, P. Değirmenci, B. Dede, C. Kırmaz

{"title":"Clinical Features of Patients with Chronic Urticaria and the Results of the Skin Prick Tests","authors":"F. Bilgir, R. Özdemir, P. Değirmenci, B. Dede, C. Kırmaz","doi":"10.21911/AAI.437","DOIUrl":"https://doi.org/10.21911/AAI.437","url":null,"abstract":"Objective: Chronic urticaria (CU), which is mostly idiopathic, may also be a sign of an allergic or systemic disease. A variety of diseases and allergens that accompany CU have been reported in various studies. The aim of this study was to investigate the factors that play a role in the etiology of CU. Materials and Methods: The demographic and clinical data from 302 patients – aged over 18 years - who were being monitored for CU were recorded. Several tests were performed to analyze comorbidities such as infection, malignancy, and autoimmune and rheumatic diseases. Skin Prick Test (SPT) results and questionnaires were reviewed. Results: Two hundred and thirteen out of the 302 patients with a mean age of 40.26±14.3 years were females. The duration of CU was 43.30±62.60 months and 42.9% of the patients had comorbidities. The most common disease was autoimmune thyroiditis (13.9%). Fifty-five percent of the patients were sensitive to inhalant allergens, and 5% exhibited allergen positivity for food. The most common allergens were house (43.7%) dust mites. Allergen positivity was 37.2% in those with comorbidities, while it was 62.8% in those without any comorbidities and this relationship was statistically significant (p<0.05). Conclusion: This study showed that there was an association between house dust mite and CU dust sensitivity. House dust mite sensitivity may trigger CU.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2019-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45443921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Urticaria in a 12-Year-Old Female Patient Undergoing Traditional Cautery Therapy: Case Report 12岁女患者行传统烧灼治疗致荨麻疹1例

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-04-21 DOI: 10.21911/AAI.397

S. B. Eltan, E. Kuçukosmanoglu, Abdülkadir Usta, O. Keskin

引用次数: 0

Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks 土耳其遗传性血管性水肿患者使用C1抑制剂治疗急性发作的意见

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-04-21 DOI: 10.21911/AAI.439

S. Demir, M. Olgac, Derya Unal, Raif Coşkun, A. Gelincik, B. Çolakoğlu, S. Büyüköztürk

{"title":"Opinions of Turkish Hereditary Angioedema Patients Regarding the Use of C1 Inhibitor Concentrate in the Treatment of Acute Attacks","authors":"S. Demir, M. Olgac, Derya Unal, Raif Coşkun, A. Gelincik, B. Çolakoğlu, S. Büyüköztürk","doi":"10.21911/AAI.439","DOIUrl":"https://doi.org/10.21911/AAI.439","url":null,"abstract":"Objective: No data exists about the perceptions of Turkish hereditary angioedema patients regarding the use of C1 inhibitor concentrate that has been used in the treatment of acute attacks for the last 7 years. Our aim was to evaluate patient opinions about the C1 inhibitor (C1-inh) concentrate and determine the level of satisfaction with this drug. Materials and Methods: Fifty-seven hereditary angioedema (HAE) patients who used C1-inh concentrate for their angioedema attacks were asked to complete a questionnaire which contained various questions related to demographic information, clinical features, and experiences with C1-inh concentrate use. Results: Sixty-five % of the patients were female and 94.7% of the patients had type 1 HAE. The mean curent age and age of diagnosis were 38.11±12.6 and 29.95±13.85 years, respectively. Thirteen patients did not have a family history. Forty patients were under prophylaxis (danazol n=39, tranexamic acid= 1). The mean duration of the C1-inh concentrate usage was 4.07±1.76 years. The patients had taken this drug 6 times over the past year on average. All patients stated that they experienced difficulties during injections with this medication in the emergency units due to a lack of awareness by health care professionals regarding both HAE and C1-inh concentrate. While 61.4% of the patients reported overall satisfaction about the efficacy of drug, 43.8% stated that this medication should have a more practical application; 52.6% proposed that the drug should be more accessible in hospital emergency rooms. Conclusion: Patients with HAE generally considered that C1-inh concentrate was effective in their attacks. However, this group of patients expressed concerns related to the medical personnel’s awareness about HAE as well as access to the medication.","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2019-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48504489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Successful Immunoglobulin Replacement with Subcutaneous Immunoglobulin Therapy in a Patient with Primary Intestinal Lymphangiectasia 皮下免疫球蛋白治疗原发性肠淋巴管扩张患者的成功免疫球蛋白替代疗法

IF 0.2

Astim Allerji Immunoloji Pub Date : 2019-04-21 DOI: 10.21911/aai.442

G. Aytekin, Fatih Çölkesen, Ö. Ardeniz, Z. Caliskaner

引用次数: 1